Controversies in Modern Eye Care 2023: Pearls in managing glaucoma

Video

Danica J. Marrelli, OD, FAAO, shares highlights from the glaucoma panel, which she was part of during the 17th annual Controversies in Modern Eye Care meeting.

Danica J. Marrelli, OD, FAAO, shares key takeaways from her featured symposium, "Pearls in comanging glaucoma," which she co-presented during the 17th annual Controversies in Modern Eye Care symposium at the Skirball Cultural Center in Los Angeles, California.

This transcript has been edited for clarity.

Danica J. Marelli, OD, FAAO:

Hi, I'm Danica Marrelli, an optometrist from Houston, Texas, and today I was on part of the glaucoma panel.

I was talking about our traditional medical therapies and where there's really kind of an unmet need, where for really about 25 years, we haven't been paying attention medically to the trabecular meshwork in the conventional outflow pathway, but we have some newer medications that really target that. And it's really something that we need to be aware of so that we're targeting the main resistance to outflow area for our glaucoma patients.

I think it's very easy for doctors to get very set in their ways. We use the same medications over and over and a new medication comes out and you still don't know exactly where it fits. And so I hope that today's presentation kind of reminded [attendees] of these newer medications and the fact that they're really important. They work very well, patients tolerate them, and they definitely have a role in our medical management of glaucoma patients.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.